You are browsing articles on the topic of Prevention Archives - CardioExchange

Avatar of Amy Herman, CardioExchange Staff

USPSTF Finalizes Recommendations on Carotid Artery Stenosis Screening (8 Jul 2014)

News

The U.S. Preventive Services Task Force has recommended against screening for asymptomatic carotid artery stenosis in the general adult population (grade D recommendation). Published in the Annals of Internal Medicine, the statement reiterates the group’s 2007 guidance. The harms of screening outweigh the benefits, the task force says. The groups notes that all screening strategies…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Ben

Statins Are a Mess: We Need Better Data, and Shared Decision Making (7 Jul 2014)

Voices

Ben Goldacre, MB, BS, BA, MA, MBBS, MSc

The following open letter was originally published on The British Medical Journal‘s editorial page regarding the adverse effects of statins for patients with low risk of cardiovascular disease. It was written in response to an analysis by Abramson et al, and more information on the subject can be found here. I have two observations to…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Sitagliptin Associated with Increase in Heart Failure Hospitalizations (3 Jul 2014)

News

The cardiovascular effects of drugs used for glucose control in patients with diabetes have been a subject of controversy for many years now. More recently, attention has started to focus specifically on the risk for heart failure (HF). Now, an observational study will likely raise new questions about the dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin (Januvia, Merck)….

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

FDA Recalls Another Batch of Generic Metoprolol (24 Jun 2014)

News

The FDA has recalled more than 13,000 bottles of metoprolol succinate extended-release tablets manufactured by Dr. Reddy’s Laboratories. In addition, the agency recently recalled another lot of generic metoprolol from a different company, Wockhardt. Both recalls were for medicines manufactured at facilities in India. There have been multiple reports in recent years of problems with generic…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Mobile Cardiovascular Screening Programs Come Under Fire (23 Jun 2014)

News

The consumer group Public Citizen has urged 20 hospitals to sever their involvement in a mobile cardiovascular screening program. The HealthFair Cardiovascular Screening Packages are unethical, mislead consumers, and do more harm than good, according to Public Citizen. In a statement, the president of the American College of Cardiology, Patrick O’Gara, said that “the questions…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

If You Snus, You Lose: Study Shows Benefits of Quitting Smokeless Tobacco (23 Jun 2014)

News

The adverse effects of smoking are well known and documented. The effect of smokeless tobacco is less clear. Now a study from Sweden, published in Circulation, offers evidence that quitting smokeless tobacco after MI is about as beneficial as quitting smoking. The results do not support the common view that smokeless tobacco is a safe alternative…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Genetic Studies May Help Unravel the Triglyceride Problem (19 Jun 2014)

News

The precise role of triglycerides in heart disease has been very difficult to determine. To help untangle the knotty problem two research groups studied large populations and identified rare variations in a gene (APOC3) that encodes for apolipoprotein C3, which is known to increase triglyceride levels. In the first paper, published in the New England…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Jay

Case: Smoking-Related CV Risk and the Need for Statin Therapy in a Former Smoker Who Quit Long Ago (16 Jun 2014)

Cardiology Case Discussion

Jay D Shah, MD, Neil J Stone, MD, and James Fang, MD

Jay Shah presents the case of a 66-year-old woman who quit smoking 15 years ago and is seen for a cardiovascular risk assessment.

Avatar of Larry Husten, PHD

European Regulators Investigate Cardiovascular Safety of Ibuprofen (16 Jun 2014)

News

The European Medicines Agency announced on Friday that it had initiated a review of the cardiovascular safety of ibuprofen when taken in high doses over an extended period of time. The review will be performed by the Pharmacovigilance Risk Assessment Committee (PRAC). The EMA said that people taking ibuprofen should continue to take it as long as they follow…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Major Medical Organizations Establish Ambitious Diabetes Registry (10 Jun 2014)

News

Our knowledge of diabetes today is a bit like the way blind men understand an elephant. With a myriad of isolated perspectives it’s nearly impossible to gain a broad overview. Now, a new initiative from a group of major medical organization will seek to provide the tools to better see a full picture of the elephantine…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.